R&D Why clinical trials lose a quarter of their patients before ... Data fragmentation creates unnecessary burden on sponsors and the people clinical trials aim to serve.
Digital Pharma’s next security problem isn’t the code. It’s what the... As AI becomes embedded throughout development, innovation must be matched by equally sophisticated approaches to software security.
Market Access HHS guidance on using online tracking technologies: How to m... In December 2022, the US Department of Health and Human Services (HHS) Office for Civil Rights (OCR) issued guidance on online tracking technology to HIPAA-covered entities.
Views & Analysis Specialty pharma’s next big opportunity: it’s time for patie... In January 2020, the financial conglomerate Visa
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.